enta-ex231_11.htm

EX-23.1 6 enta-ex231_11.htm EX-23.1 enta-ex231_11.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-189217, 333-192935, 333-202257, 333-209542 and 333-215011) of Enanta Pharmaceuticals, Inc. of our report dated December 11, 2017 relating to the financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

December 11, 2017